NEW YORK--(BUSINESS WIRE)--Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced results of a well ...
The study underscores Small Pharma's core mission, which is patient access, CEO George Tziras says. The company hopes to be one step closer to understanding the potential efficacy of SPL026 as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback